These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. Nelson JS, McCullough JL, Berns MW. J Natl Cancer Inst; 1988 Mar 02; 80(1):56-60. PubMed ID: 2963136 [Abstract] [Full Text] [Related]
5. Distribution and elimination of Photofrin II in mice. Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ. Photochem Photobiol; 1989 Aug 02; 50(2):221-8. PubMed ID: 2528753 [Abstract] [Full Text] [Related]
7. The effect of glucose administration on the uptake of photofrin II in a human tumor xenograft. Peng Q, Moan J, Cheng LS. Cancer Lett; 1991 Jun 14; 58(1-2):29-35. PubMed ID: 1828712 [Abstract] [Full Text] [Related]
9. Location of P-II and AlPCS4 in human tumor LOX in vitro and in vivo by means of computer-enhanced video fluorescence microscopy. Peng Q, Moan J, Farrants GW, Danielsen HE, Rimington C. Cancer Lett; 1991 Jun 14; 58(1-2):37-47. PubMed ID: 1828713 [Abstract] [Full Text] [Related]
10. Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy. Koshida K, Hisazumi H, Komatsu K, Hirata A, Uchibayashi T. Urol Res; 1993 Jun 14; 21(4):283-8. PubMed ID: 8212418 [Abstract] [Full Text] [Related]
11. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin. Margaron P, Madarnas P, Quellet R, Van Lier JE. Anticancer Res; 1996 Jun 14; 16(2):613-20. PubMed ID: 8687105 [Abstract] [Full Text] [Related]
12. Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour. Yumita N, Umemura S. J Pharm Pharmacol; 2004 Jan 14; 56(1):85-90. PubMed ID: 14980005 [Abstract] [Full Text] [Related]
13. Comparative study of the therapeutic effect of photoactivated hematoporphyrin derivative and aluminum disulfonated phthalocyanines on tumor bearing mice. Canti G, Franco P, Marelli O, Cubeddu R, Taroni P, Ramponi R. Cancer Lett; 1990 Sep 14; 53(2-3):123-7. PubMed ID: 2208071 [Abstract] [Full Text] [Related]
14. Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment. Kashtan H, Haddad R, Yossiphov Y, Bar-On S, Skornick Y. Dis Colon Rectum; 1996 Apr 14; 39(4):379-83. PubMed ID: 8878495 [Abstract] [Full Text] [Related]
15. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Lilge L, Wilson BC. J Clin Laser Med Surg; 1998 Apr 14; 16(2):81-91. PubMed ID: 9663099 [Abstract] [Full Text] [Related]
16. Photodynamic therapy of oncogene-transformed cells. Pass HI, Evans S, Matthews WA, Perry R, Venzon D, Roth JA, Smith P. J Thorac Cardiovasc Surg; 1991 May 14; 101(5):795-9. PubMed ID: 1827169 [Abstract] [Full Text] [Related]
17. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. Peng Q, Moan J. Br J Cancer; 1995 Sep 14; 72(3):565-74. PubMed ID: 7669563 [Abstract] [Full Text] [Related]
18. Intravenous vs intraperitoneal sensitizer: implications for intraperitoneal photodynamic therapy. Perry RR, Smith PD, Evans S, Pass HI. Photochem Photobiol; 1991 Mar 14; 53(3):335-40. PubMed ID: 1829531 [Abstract] [Full Text] [Related]